Abstract

Non-coding RNAs (ncRNAs) play a key role in the regulation of transcriptional and epigenetic activity in mammalian cells. Comprehensive analysis of these ncRNAs has revealed sophisticated gene regulatory mechanisms which finely tune the proper gene output required for cellular homeostasis, proliferation, and differentiation. However, this elaborate circuitry has also made it vulnerable to perturbations that often result in disease. Among the many types of ncRNAs, long non-coding RNAs (lncRNAs) appear to have the most diverse mechanisms of action including competitive binding to miRNA targets, direct binding to mRNA, interactions with transcription factors, and facilitation of epigenetic modifications. Moreover, many lncRNAs display tissue-specific expression patterns suggesting an important regulatory role in organogenesis, yet the molecular mechanisms through which these molecules regulate cardiac and skeletal muscle development remains surprisingly limited. Given the structural and metabolic similarities of cardiac and skeletal muscle, it is likely that several lncRNAs expressed in both of these tissues have conserved functions in establishing the striated muscle phenotype. As many aspects of regeneration recapitulate development, understanding the role lncRNAs play in these processes may provide novel insights to improve regenerative therapeutic interventions in cardiac and skeletal muscle diseases. This review highlights key lncRNAs that function as regulators of development, regeneration, and disease in cardiac and skeletal muscle. Finally, we highlight lncRNAs encoded by imprinted genes in striated muscle and the contributions of these loci on the regulation of gene expression.

Highlights

  • A small percentage (

  • This review focuses on key long non-coding RNAs (lncRNAs) published in the literature which are known to play a critical role in cardiac and skeletal muscle development, regeneration, and disease

  • While many lncRNAs are predominately expressed in a tissue-specific manner, there are a number of lncRNAs that have been identified to be expressed in both cardiac and skeletal muscle (Figure 1)

Read more

Summary

Introduction

A small percentage (16,000) in the mammalian genome [1,9,10]. This information can be used to improve regenerative therapeutic interventions for a spectrum of muscle diseases

Cardiac Development
Cardiac Muscle Regeneration
Cardiac Hypertrophy
Myocardial Infarction
Skeletal Muscle Development
Skeletal Muscle Differentiation and Regeneration
Positive Regulators
Negative Regulators
Skeletal Muscle Disease
LncRNAs That Function as ncRNAs and Micropeptides
LncRNAs Co-Expressed in Cardiac and Skeletal Muscle
LncRNAs
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.